BASIS OF PRESENTATION (Details)	9 Months Ended
Nov. 30, 2024 item
BASIS OF PRESENTATION
Percentage of outstanding stock owned by the President and Chairman of the Board	81.00%
Number of antineoplaston drugs that have received FDA approval	0

Represents the percentage interest of ownership held by the President of the Company, whom is also the Chairman of the Board.

No definition available.

Name:	bzyr_OwnershipInterestPercentageHeldByCompanyPresidentAndChairmanOfBoard
Namespace Prefix:	bzyr_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	instant